Phase I study of anti-PD1 in combination with low-dose decitabine in patients with advanced and untreated malignancies.

e14555Background: Anti-PD1 have produced significant antitumor activity in multiply malignancies, however, resistance to anti-PD1 is becoming increasingly apparent in recent years. Low-dose decitab...